Arai Y - Search Results

1

Volume-weighted mean nuclear volume predicts tumor biology of clinically organ-confined prostate cancer.

Arai Y, Okubo K, Terada N, Matsuta Y, Egawa S, Kuwao S, Ogura K. Arai Y, et al. Prostate. 2001 Feb 1;46(2):134-41. doi: 10.1002/1097-0045(20010201)46:2<134::aid-pros1017>3.0.co;2-9. Prostate. 2001. PMID: 11170141

2

[PSATZ (prostate specific antigen adjusted for the transition zone volume)].

Maeda H, Okubo K, Arai Y. Maeda H, et al. Among authors: arai y. Nihon Rinsho. 1998 Aug;56(8):2016-20. Nihon Rinsho. 1998. PMID: 9750499 Review. Japanese.

3

A study of pretreatment nomograms to predict pathological stage and biochemical recurrence after radical prostatectomy for clinically resectable prostate cancer in Japanese men.

Egawa S, Suyama K, Arai Y, Matsumoto K, Tsukayama C, Kuwao S, Baba S. Egawa S, et al. Among authors: arai y. Jpn J Clin Oncol. 2001 Feb;31(2):74-81. doi: 10.1093/jjco/hye018. Jpn J Clin Oncol. 2001. PMID: 11302346

4

Racial differences in cellular composition of benign prostatic hyperplasia.

Aoki Y, Arai Y, Maeda H, Okubo K, Shinohara K. Aoki Y, et al. Among authors: arai y. Prostate. 2001 Dec 1;49(4):243-50. doi: 10.1002/pros.10019. Prostate. 2001. PMID: 11746270

5

The role of volume-weighted mean nuclear volume in predicting tumour biology and clinical behaviour in patients with prostate cancer undergoing watchful waiting.

Arai Y, Egawa S, Kuwao S, Ogura K, Baba S. Arai Y, et al. BJU Int. 2001 Dec;88(9):909-14. doi: 10.1046/j.1464-4096.2001.01558.x. BJU Int. 2001. PMID: 11851612

6

Volume-weighted mean nuclear volume predicts tumour biology after radical prostatectomy.

Arai Y, Okubo K, Terada N, Matsuta Y, Egawa S, Kuwao S, Ogura K. Arai Y, et al. Prostate Cancer Prostatic Dis. 2000 Dec;3(S1):S4. doi: 10.1038/sj.pcan.4500428. Prostate Cancer Prostatic Dis. 2000. PMID: 12497114 No abstract available.

7

Impact of biochemical failure on long-term clinical outcome after radical prostatectomy for prostate cancer in Japan.

Egawa S, Matsui Y, Matsumoto K, Suyama K, Arai Y, Kuwao S, Baba S. Egawa S, et al. Among authors: arai y. Prostate Cancer Prostatic Dis. 2004;7(2):152-7. doi: 10.1038/sj.pcan.4500715. Prostate Cancer Prostatic Dis. 2004. PMID: 15175664

8

Prostate-specific antigen adjusted for total prostatic tumor volume as a predictor for outcome after radical prostatectomy.

Hayashi N, Urashima M, Ikemoto I, Kuruma H, Arai Y, Kuwao S, Baba S, Egawa S. Hayashi N, et al. Among authors: arai y. Prostate Cancer Prostatic Dis. 2007;10(1):60-5. doi: 10.1038/sj.pcan.4500902. Epub 2006 Oct 3. Prostate Cancer Prostatic Dis. 2007. PMID: 17003775

9

Prostate specific antigen adjusted for the transition zone volume as an indicator of prostate cancer.

Maeda H, Arai Y, Ishitoya S, Okubo K, Aoki Y, Okada T. Maeda H, et al. Among authors: arai y. J Urol. 1997 Dec;158(6):2193-6. doi: 10.1016/s0022-5347(01)68193-x. J Urol. 1997. PMID: 9366342 Clinical Trial.

10

Prospective evaluation of prostate specific antigen density and systematic biopsy for detecting prostate cancer in Japanese patients with normal rectal examinations and intermediate prostate specific antigen levels.

Arai Y, Maeda H, Ishitoya S, Okubo K, Okada T, Aoki Y. Arai Y, et al. J Urol. 1997 Sep;158(3 Pt 1):861-4. doi: 10.1097/00005392-199709000-00046. J Urol. 1997. PMID: 9258099 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,199 results

Search Page

Filters